<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-91319" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Thyrotoxic Periodic Paralysis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Siddamreddy</surname>
            <given-names>Suman</given-names>
          </name>
          <aff>UAMS, Baptist</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dandu</surname>
            <given-names>Vasuki H.</given-names>
          </name>
          <aff>Baptist Health</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Suman Siddamreddy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vasuki Dandu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-91319.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Thyrotoxic periodic paralysis is a sporadic form of hypokalemic periodic paralysis, which most commonly presents as sudden onset weakness in the proximal muscles. It is a reversible condition that can be treated with quick replacement of potassium and normalization of thyroid hormones. This activity reviews the pathogenesis, clinical features, laboratory findings of thyrotoxic periodic paralysis, and highlights the role of the interprofessional team in the diagnosis and treatment of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of thyrotoxic periodic paralysis.</p></list-item><list-item><p>Explain the common physical examination findings in patients with thyrotoxic periodic paralysis.</p></list-item><list-item><p>Outline the management of patients with thyrotoxic periodic paralysis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=91319&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=91319">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-91319.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Thyrotoxic periodic paralysis (TPP) is an uncommon but dangerous complication seen in thyrotoxic patients. It is characterized by hypokalemia associated with acute proximal symmetrical lower limb weakness and can progress to involve all four limbs and the respiratory musculature. The mechanisms of hypokalemia are incompletely understood. The prevailing theories include increased Na-K ATPase pump activity and mutations in genes encoding Kir channels in skeletal muscle. It is often confused with familial periodic paralysis (FPP) due to the similarity in presentation but can be differentiated based on the presence of thyrotoxic features and biochemical testing. Commonly recorded and described in East Asian males, the incidence of TPP has been rising in the West and other parts of the world. Knowledge regarding identification, early treatment, and prevention of future episodes of TPP is essential in mitigating this potentially lethal complication.</p>
      </sec>
      <sec id="article-91319.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Any cause of hyperthyroidism can lead to thyrotoxic periodic paralysis. They include Grave disease (most common), toxic nodular goiter, solitary toxic nodule, iodine-induced thyrotoxicosis, excess exogenous thyroxine use, thyroiditis, thyrotropin-secreting pituitary adenoma, and amiodarone-induced thyrotoxicosis.<xref ref-type="bibr" rid="article-91319.r1">[1]</xref><xref ref-type="bibr" rid="article-91319.r2">[2]</xref></p>
        <p>Common factors triggering attacks of periodic paralysis include the consumption of carbohydrate-rich foods, strenuous physical activity, high salt/sodium intake, stresses (surgical, infectious, psychological), trauma, and drugs (diuretics, estrogens, acetazolamide, epinephrine, laxatives, corticosteroids, non-steroidal anti-inflammatory drugs, licorice, fluoroquinolones, aminoglycosides, and ecstasy).<xref ref-type="bibr" rid="article-91319.r1">[1]</xref><xref ref-type="bibr" rid="article-91319.r3">[3]</xref><xref ref-type="bibr" rid="article-91319.r4">[4]</xref><xref ref-type="bibr" rid="article-91319.r5">[5]</xref><xref ref-type="bibr" rid="article-91319.r6">[6]</xref><xref ref-type="bibr" rid="article-91319.r7">[7]</xref><xref ref-type="bibr" rid="article-91319.r8">[8]</xref></p>
      </sec>
      <sec id="article-91319.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>TPP has been well-documented in the Asian population. Reported incidences vary from 1.9% in Japanese thyrotoxic patients to 1.8% in Chinese thyrotoxic patients.<xref ref-type="bibr" rid="article-91319.r9">[9]</xref><xref ref-type="bibr" rid="article-91319.r6">[6]</xref>&#x000a0;Data on the incidence rate in the West is mostly unknown, with one study reporting a rate between 0.1% to 0.2% in thyrotoxic patients in North America.<xref ref-type="bibr" rid="article-91319.r4">[4]</xref>&#x000a0;Recently, however, the incidence of TPP in Western countries has increased, whereas the incidence in Japan has reduced.<xref ref-type="bibr" rid="article-91319.r10">[10]</xref><xref ref-type="bibr" rid="article-91319.r11">[11]</xref></p>
        <p>Cases of TPP have also been reported in children,&#x000a0;Europeans, Hispanics, Indians, Malaysians, Vietnamese, Saudis, Polynesians, and the Turkish populations.<xref ref-type="bibr" rid="article-91319.r12">[12]</xref><xref ref-type="bibr" rid="article-91319.r13">[13]</xref><xref ref-type="bibr" rid="article-91319.r8">[8]</xref><xref ref-type="bibr" rid="article-91319.r14">[14]</xref>&#x000a0;Several studies have shown thyrotoxic males have a much higher incidence of TPP compared to females, albeit the higher incidence of thyrotoxicosis in females.<xref ref-type="bibr" rid="article-91319.r15">[15]</xref><xref ref-type="bibr" rid="article-91319.r5">[5]</xref><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="32160042">[16]</ext-link><xref ref-type="bibr" rid="article-91319.r16">[17]</xref><xref ref-type="bibr" rid="article-91319.r17">[18]</xref>&#x000a0;The incidence among Japanese thyrotoxic patients was recorded as 4.3% in males and 0.04% in females.<xref ref-type="bibr" rid="article-91319.r18">[19]</xref> In the Chinese, thyrotoxic males demonstrated an incidence of 13% compared to 0.13% in thyrotoxic females.<xref ref-type="bibr" rid="article-91319.r6">[6]</xref>&#x000a0;It usually manifests around the age of 30-50<bold>.</bold><xref ref-type="bibr" rid="article-91319.r6">[6]</xref><xref ref-type="bibr" rid="article-91319.r19">[20]</xref><xref ref-type="bibr" rid="article-91319.r20">[21]</xref><xref ref-type="bibr" rid="article-91319.r21">[22]</xref></p>
      </sec>
      <sec id="article-91319.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The mechanism of TPP involves two major factors: the occurrence of hypokalemia and associated muscle paralysis. Skeletal muscles house the largest share of total body potassium in the body (2600mmol) and play a vital role in maintaining extracellular potassium homeostasis. This balance is maintained by the sarcolemmal Na-K ATPase pumps and K channels. The former regulates the intracellular movement of potassium, whereas the latter, including the inward rectifying (Kir) and delayed rectifying potassium channels, regulates the extracellular movement of potassium.<xref ref-type="bibr" rid="article-91319.r22">[23]</xref></p>
        <p>Thyrotoxicity can contribute to hypokalemia by a direct increase in the genetic transcription of genes coding for the Na-K ATPase pump as well as an increase in the pump's intrinsic activity.<xref ref-type="bibr" rid="article-91319.r23">[24]</xref><xref ref-type="bibr" rid="article-91319.r24">[25]</xref>&#x000a0;Thyroid hormones also cause Beta-2 adrenergic stimulation and a rise in sensitivity to circulating catecholamines, resulting in an increase in Na-K pump activity.<xref ref-type="bibr" rid="article-91319.r25">[26]</xref></p>
        <p>Hyperinsulinemia seen in attacks of TPP may also contribute to a depletion in extracellular potassium.<xref ref-type="bibr" rid="article-91319.r26">[27]</xref><xref ref-type="bibr" rid="article-91319.r27">[28]</xref>&#x000a0;Increased Androgen levels, characteristically seen in males, have been associated with increased Na-K pump activity as well.<xref ref-type="bibr" rid="article-91319.r28">[29]</xref>&#x000a0;Loss-of-function mutations in the genes encoding muscle-specific Kir channels (Kir2.6), can prevent the flow of potassium out of skeletal muscle cells, disrupting potassium homeostasis.<xref ref-type="bibr" rid="article-91319.r29">[30]</xref>&#x000a0;These mutations have been identified in up to a third of TPP patients.<xref ref-type="bibr" rid="article-91319.r30">[31]</xref>&#x000a0;Furthermore, insulin and catecholamines have also been shown to inhibit Kir channels.<xref ref-type="bibr" rid="article-91319.r31">[32]</xref>&#x000a0;Following the reduction in extracellular potassium, the sarcolemmal membrane depolarizes, rather than hyperpolarizing. This paradoxical effect leads to the inactivation of sarcolemmal sodium channels, causing the pathognomonic paralysis of skeletal muscles.<xref ref-type="bibr" rid="article-91319.r32">[33]</xref><xref ref-type="bibr" rid="article-91319.r33">[34]</xref>&#x000a0;Thyroid hormones have been shown to upregulate transcription oKir channels.</p>
      </sec>
      <sec id="article-91319.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients usually present with sudden onset of episodic muscle weakness, more in the proximal muscle compared to distal, along with myalgias. Weakness is also more common in lower extremities compared to upper extremities. Paralytic symptoms usually appear after symptoms of hyperthyroidism appear. They might also present with palpitations, tachycardia, dyspnea, dysphagia, and speech and visual changes. Some patients might present with rhabdomyolysis.<xref ref-type="bibr" rid="article-91319.r34">[35]</xref>&#x000a0;Patients might also present with other hyperthyroid symptoms, including heat intolerance, hyper defecation, goiter, and exophthalmos.<xref ref-type="bibr" rid="article-91319.r35">[36]</xref>&#x000a0;On examination, they might have ectopic heartbeats, tachycardia, decreased or lack of reflexes. Usually, patients regain strength in between attacks, but weakness can persist with recurrent attacks. Attacks are more common in early mornings and usually precipitated after a heavy carbohydrate meal or after strenuous exercise.<xref ref-type="bibr" rid="article-91319.r36">[37]</xref></p>
      </sec>
      <sec id="article-91319.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Hypokalemia is present in most of the patients. Hypomagnesemia and Hypophosphatemia are also present in some patients which might be one of the distinguishing features from other forms of familial periodic paralysis.<xref ref-type="bibr" rid="article-91319.r37">[38]</xref>&#x000a0;Abnormal thyroid hormones like elevated T4, or elevated T3 and low thyrotropin (TSH) might be present. The thyroid uptake scan might show increased uptake.</p>
        <p>Abnormal electrocardiograms with arrhythmias might be present. The most common Electrocardiogram (EKG) changes include ST depression, sinus tachycardia, U waves, and AV blocks.<xref ref-type="bibr" rid="article-91319.r38">[39]</xref>&#x000a0;Very rarely, they can present with prolonged QT interval or ventricular tachyarrhythmias. Electromyograms might show a myopathic pattern with decreased duration of muscle action potentials, reduced amplitude, and an increase in polyphasic potentials. These changes might completely disappear during remission.<xref ref-type="bibr" rid="article-91319.r39">[40]</xref></p>
      </sec>
      <sec id="article-91319.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Here are important treatment goals:</p>
        <list list-type="bullet">
          <list-item>
            <p>The goal is to quickly supplement potassium along with the reduction of thyroid hormones. We need to monitor for the risk of rebound hyperkalemia and hyperphosphatemia during the recovery phase.</p>
          </list-item>
          <list-item>
            <p>Intravenous potassium replacement is preferred, especially when patients present with severe symptoms, especially arrhythmias.&#x000a0;Acute treatment suggestion is with&#x000a0;30 mEq of potassium given orally, every two hours until recovery begins, with a maximum oral dose of 90 mEq in 24 hours. Some suggestions include replacing at a rate of less than 10 mEq orally.</p>
          </list-item>
          <list-item>
            <p>Prophylactic potassium supplementation between attacks has not shown to be beneficial.<xref ref-type="bibr" rid="article-91319.r36">[37]</xref></p>
          </list-item>
          <list-item>
            <p>Non-selective beta-blockers have been shown to improve neuromuscular symptoms by reducing the intracellular shift of phosphate and potassium.<xref ref-type="bibr" rid="article-91319.r40">[41]</xref>&#x000a0;Intravenous propranolol 1 mg every 10 minutes up to 3 doses can be given in patients unresponsive to potassium replacement.<xref ref-type="bibr" rid="article-91319.r41">[42]</xref></p>
          </list-item>
          <list-item>
            <p>Medications that induce hypokalemia like glucocorticoids should be carefully monitored and should be avoided if possible in these patients. The ultimate goal is to reduce thyroid hormone levels and restore euthyroid status.</p>
          </list-item>
          <list-item>
            <p>Antithyroid drugs, radioactive iodine, and or surgery might be necessary based on the etiology of hyperthyroidism.</p>
          </list-item>
          <list-item>
            <p>Precipitating factors like strenuous exercise and high carbohydrate meals should be avoided.<xref ref-type="bibr" rid="article-91319.r42">[43]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-91319.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other muscular disorders like myasthenia gravis, Guillain Barre syndrome, transverse myelitis, botulism, tick paralysis, and other familial periodic paralysis syndromes should be ruled out when patients present with acute muscle weakness.<xref ref-type="bibr" rid="article-91319.r34">[35]</xref></p>
      </sec>
      <sec id="article-91319.s10" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education is one of the very important steps in treating and preventing the disease.</p>
        <p>Patients should be educated about symptoms, including muscle weakness, arrhythmias, and symptoms related to hyperthyroidism, including heat intolerance, goiter, hyper defecation, and exophthalmos.&#x000a0;They should avoid heavy meals, intense exercise, high sodium intake, etc.</p>
        <p>Patients are instructed to go to the nearest emergency room if they experience any of the symptoms of thyrotoxic periodic paralysis.</p>
      </sec>
      <sec id="article-91319.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Thyrotoxic periodic paralysis is a sporadic form of hypokalemic periodic paralysis, which most commonly presents as sudden onset weakness in the proximal muscles. It is a reversible condition that can be treated with quick replacement of potassium and normalization of thyroid hormones.&#x000a0;Interprofessional communication by the total team is essential to timely treat these patients and minimize complications.</p>
        <p>Pharmacists should be very vigilant when dispensing intravenous potassium, and they should clearly label the instructions about how to infuse the drug, as it can cause complications, including local skin reactions to severe complications like fatal arrhythmias if given too fast. Nursing staff should double-check the instructions on electrolyte infusion bags to prevent complications. The patients need to be carefully monitored for any rebound symptoms from hyperkalemia and hyperphosphatemia. The discharge staff should provide educational materials for patients and family members upon discharge, as this&#x000a0;can be a recurrent condition.</p>
      </sec>
      <sec id="article-91319.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=91319&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=91319">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/thyrotoxic-periodic-paralysis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=91319">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/91319/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=91319">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-91319.s13">
        <title>References</title>
        <ref id="article-91319.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic periodic paralysis.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2005</year>
            <month>Jan</month>
            <volume>80</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-105</page-range>
            <pub-id pub-id-type="pmid">15667036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chou</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents.</article-title>
            <source>Am J Med Sci</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>337</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-3</page-range>
            <pub-id pub-id-type="pmid">19002009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Laboratory tests to determine the cause of hypokalemia and paralysis.</article-title>
            <source>Arch Intern Med</source>
            <year>2004</year>
            <month>Jul</month>
            <day>26</day>
            <volume>164</volume>
            <issue>14</issue>
            <fpage>1561</fpage>
            <page-range>1561-6</page-range>
            <pub-id pub-id-type="pmid">15277290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ober</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1992</year>
            <month>May</month>
            <volume>71</volume>
            <issue>3</issue>
            <fpage>109</fpage>
            <page-range>109-20</page-range>
            <pub-id pub-id-type="pmid">1635436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Malabanan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone.</article-title>
            <source>Endocr Pract</source>
            <year>2006</year>
            <season>Jul-Aug</season>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>427</fpage>
            <page-range>427-31</page-range>
            <pub-id pub-id-type="pmid">16901800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McFadzean</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Periodic paralysis complicating thyrotoxicosis in Chinese.</article-title>
            <source>Br Med J</source>
            <year>1967</year>
            <month>Feb</month>
            <day>25</day>
            <volume>1</volume>
            <issue>5538</issue>
            <fpage>451</fpage>
            <page-range>451-5</page-range>
            <pub-id pub-id-type="pmid">6017520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hsieh</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lyu</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>WN</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Ro</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks.</article-title>
            <source>Eur J Neurol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>559</fpage>
            <page-range>559-64</page-range>
            <pub-id pub-id-type="pmid">18410374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forrest</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Platts</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ecstasy-induced thyrotoxic periodic paralysis.</article-title>
            <source>BMJ Case Rep</source>
            <year>2009</year>
            <volume>2009</volume>
            <pub-id pub-id-type="pmid">22190983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>OKINAKA</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>SHIZUME</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>IINO</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>WATANABE</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>IRIE</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>NOGUCHI</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>KUMA</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>KUMA</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>ITO</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The association of periodic paralysis and hyperthyroidism in Japan.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1957</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>12</issue>
            <fpage>1454</fpage>
            <page-range>1454-9</page-range>
            <pub-id pub-id-type="pmid">13481091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kung</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>91</volume>
            <issue>7</issue>
            <fpage>2490</fpage>
            <page-range>2490-5</page-range>
            <pub-id pub-id-type="pmid">16608889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shizume</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shishiba</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kuma</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Noguchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tajiri</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Noh</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the incidence of association of periodic paralysis and hyperthyroidism in Japan in 1957 and 1991.</article-title>
            <source>Endocrinol Jpn</source>
            <year>1992</year>
            <month>Jun</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>315</fpage>
            <page-range>315-8</page-range>
            <pub-id pub-id-type="pmid">1425456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cesur</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bayram</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Temel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Ozkaya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kocer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ertorer</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Koc</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kaya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gullu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic hypokalaemic periodic paralysis in a Turkish population: three new case reports and analysis of the case series.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>68</volume>
            <issue>1</issue>
            <fpage>143</fpage>
            <page-range>143-52</page-range>
            <pub-id pub-id-type="pmid">17897330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bazzani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benati</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bosi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iorini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Panizza</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hypokalemic thyrotoxic paralysis: a rare cause of tetraparesis with acute onset in Europeans.</article-title>
            <source>Ital J Neurol Sci</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>307</fpage>
            <page-range>307-9</page-range>
            <pub-id pub-id-type="pmid">10933451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Satam</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>More</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shanbag</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kalgutkar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Fatal thyrotoxic periodic paralysis with normokalemia.</article-title>
            <source>Indian J Pediatr</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>74</volume>
            <issue>11</issue>
            <fpage>1041</fpage>
            <page-range>1041-3</page-range>
            <pub-id pub-id-type="pmid">18057690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Hennawy</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Nesa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mahmood</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic hypokalemic periodic paralysis triggered by high carbohydrate diet.</article-title>
            <source>Am J Ther</source>
            <year>2007</year>
            <season>Sep-Oct</season>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>499</fpage>
            <page-range>499-501</page-range>
            <pub-id pub-id-type="pmid">17890941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohapatra</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Lenka</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Majhi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Oram</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tudu</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Clinical and Aetiological Spectrum of Hypokalemic Flaccid Paralysis in Western Odisha.</article-title>
            <source>J Assoc Physicians India</source>
            <year>2016</year>
            <month>May</month>
            <volume>64</volume>
            <issue>5</issue>
            <fpage>52</fpage>
            <page-range>52-58</page-range>
            <pub-id pub-id-type="pmid">27735149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kotwal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Upreti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hari Kumar</surname>
                <given-names>KVS</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic periodic paralysis: A retrospective, observational study from India.</article-title>
            <source>Indian J Med Res</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>151</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <page-range>42-46</page-range>
            <pub-id pub-id-type="pmid">32134013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sthaneshwar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prathibha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yap</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic periodic paralysis: a report of 3 Malaysian cases and a review of its pathology.</article-title>
            <source>Malays J Pathol</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-32</page-range>
            <pub-id pub-id-type="pmid">16676690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aldasouqi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bokhari</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Al-Zahrani</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic periodic paralysis in a Saudi patient complicated by life-threatening arrhythmia.</article-title>
            <source>Saudi Med J</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>564</fpage>
            <page-range>564-8</page-range>
            <pub-id pub-id-type="pmid">19370290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wilches</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Guerrero</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic periodic paralysis: diversity in America.</article-title>
            <source>J Emerg Med</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>760</fpage>
            <page-range>760-2</page-range>
            <pub-id pub-id-type="pmid">24315723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elston</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Orr-Walker</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Dissanayake</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Conaglen</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic, hypokalaemic periodic paralysis: Polynesians, an ethnic group at risk.</article-title>
            <source>Intern Med J</source>
            <year>2007</year>
            <month>May</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>303</fpage>
            <page-range>303-7</page-range>
            <pub-id pub-id-type="pmid">17504277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clausen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Hormonal and pharmacological modification of plasma potassium homeostasis.</article-title>
            <source>Fundam Clin Pharmacol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>595</fpage>
            <page-range>595-605</page-range>
            <pub-id pub-id-type="pmid">20618871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shinde</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Cockram</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Swaminathan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis.</article-title>
            <source>BMJ</source>
            <year>1991</year>
            <month>Nov</month>
            <day>02</day>
            <volume>303</volume>
            <issue>6810</issue>
            <fpage>1096</fpage>
            <page-range>1096-9</page-range>
            <pub-id pub-id-type="pmid">1660744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaudhury</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ismail-Beigi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gick</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Levenson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Edelman</surname>
                <given-names>IS</given-names>
              </name>
            </person-group>
            <article-title>Effect of thyroid hormone on the abundance of Na,K-adenosine triphosphatase alpha-subunit messenger ribonucleic acid.</article-title>
            <source>Mol Endocrinol</source>
            <year>1987</year>
            <month>Jan</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-9</page-range>
            <pub-id pub-id-type="pmid">2842662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ginsberg</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Clutter</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Cryer</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man.</article-title>
            <source>J Clin Invest</source>
            <year>1981</year>
            <month>Jun</month>
            <volume>67</volume>
            <issue>6</issue>
            <fpage>1785</fpage>
            <page-range>1785-91</page-range>
            <pub-id pub-id-type="pmid">6263953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Cheah</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Aw</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Hyperinsulinaemia in thyrotoxic hypokalaemic periodic paralysis.</article-title>
            <source>Lancet</source>
            <year>1991</year>
            <month>May</month>
            <day>04</day>
            <volume>337</volume>
            <issue>8749</issue>
            <fpage>1063</fpage>
            <page-range>1063-4</page-range>
            <pub-id pub-id-type="pmid">1673496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soonthornpun</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Setasuban</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Thamprasit</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP).</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2009</year>
            <month>May</month>
            <volume>70</volume>
            <issue>5</issue>
            <fpage>794</fpage>
            <page-range>794-7</page-range>
            <pub-id pub-id-type="pmid">18759868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guerra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rodriguez del Castillo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Battaner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Androgens stimulate preoptic area Na+,K+-ATPase activity in male rats.</article-title>
            <source>Neurosci Lett</source>
            <year>1987</year>
            <month>Jul</month>
            <day>09</day>
            <volume>78</volume>
            <issue>1</issue>
            <fpage>97</fpage>
            <page-range>97-100</page-range>
            <pub-id pub-id-type="pmid">3039424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheng</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis.</article-title>
            <source>J Biol Chem</source>
            <year>2011</year>
            <month>Aug</month>
            <day>05</day>
            <volume>286</volume>
            <issue>31</issue>
            <fpage>27425</fpage>
            <page-range>27425-35</page-range>
            <pub-id pub-id-type="pmid">21665951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryan</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Soong</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Fontaine</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Donaldson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kung</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Jongjaroenprasert</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Khoo</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Cheah</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Maciel</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Pt&#x000e1;cek</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis.</article-title>
            <source>Cell</source>
            <year>2010</year>
            <month>Jan</month>
            <day>08</day>
            <volume>140</volume>
            <issue>1</issue>
            <fpage>88</fpage>
            <page-range>88-98</page-range>
            <pub-id pub-id-type="pmid">20074522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruff</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current.</article-title>
            <source>Neurology</source>
            <year>1999</year>
            <month>Oct</month>
            <day>22</day>
            <volume>53</volume>
            <issue>7</issue>
            <fpage>1556</fpage>
            <page-range>1556-63</page-range>
            <pub-id pub-id-type="pmid">10534267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matthews</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Labrum</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sud</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Haworth</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chinnery</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Meola</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schorge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kullmann</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis.</article-title>
            <source>Neurology</source>
            <year>2009</year>
            <month>May</month>
            <day>05</day>
            <volume>72</volume>
            <issue>18</issue>
            <fpage>1544</fpage>
            <page-range>1544-7</page-range>
            <pub-id pub-id-type="pmid">19118277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puwanant</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ruff</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis.</article-title>
            <source>Muscle Nerve</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>315</fpage>
            <page-range>315-27</page-range>
            <pub-id pub-id-type="pmid">20589886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manoukian</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Foote</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Crapo</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes.</article-title>
            <source>Arch Intern Med</source>
            <year>1999</year>
            <month>Mar</month>
            <day>22</day>
            <volume>159</volume>
            <issue>6</issue>
            <fpage>601</fpage>
            <page-range>601-6</page-range>
            <pub-id pub-id-type="pmid">10090117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pompeo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nepa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maddestra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Feliziani</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Genovesi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic hypokalemic periodic paralysis: An overlooked pathology in western countries.</article-title>
            <source>Eur J Intern Med</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>380</fpage>
            <page-range>380-90</page-range>
            <pub-id pub-id-type="pmid">17693226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vijayakumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ashwath</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Thimmappa</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic periodic paralysis: clinical challenges.</article-title>
            <source>J Thyroid Res</source>
            <year>2014</year>
            <volume>2014</volume>
            <fpage>649502</fpage>
            <pub-id pub-id-type="pmid">24695373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Venance</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Fialho</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fontaine</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hanna</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Ptacek</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Tristani-Firouzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tawil</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Griggs</surname>
                <given-names>RC</given-names>
              </name>
              <collab>CINCH investigators</collab>
            </person-group>
            <article-title>The primary periodic paralyses: diagnosis, pathogenesis and treatment.</article-title>
            <source>Brain</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>129</volume>
            <issue>Pt 1</issue>
            <fpage>8</fpage>
            <page-range>8-17</page-range>
            <pub-id pub-id-type="pmid">16195244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lopez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>SO</given-names>
              </name>
            </person-group>
            <article-title>Electrocardiogram changes in Thyrotoxic Periodic Paralysis.</article-title>
            <source>West J Emerg Med</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>512</fpage>
            <page-range>512-3</page-range>
            <pub-id pub-id-type="pmid">23359336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puvanendran</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cheah</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Electromyographic (EMG) study in thyrotoxic periodic paralysis.</article-title>
            <source>Aust N Z J Med</source>
            <year>1977</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>507</fpage>
            <page-range>507-10</page-range>
            <pub-id pub-id-type="pmid">272170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>YF</given-names>
              </name>
            </person-group>
            <article-title>Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>620</fpage>
            <page-range>620-3</page-range>
            <pub-id pub-id-type="pmid">11228188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Chuang</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Potassium chloride supplementation alone may not improve hypokalemia in thyrotoxic hypokalemic periodic paralysis.</article-title>
            <source>J Emerg Med</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>263</fpage>
            <page-range>263-5</page-range>
            <pub-id pub-id-type="pmid">17394988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91319.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tessier</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Neu</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Horning</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Thyrotoxic periodic paralysis (TPP) in a 28-year-old sudanese man started on prednisone.</article-title>
            <source>J Am Board Fam Med</source>
            <year>2010</year>
            <season>Jul-Aug</season>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>551</fpage>
            <page-range>551-4</page-range>
            <pub-id pub-id-type="pmid">20616298</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
